Infectologia
A COVID se tornará uma doença de jovens? – “Uma crescente taxa de infecções entre jovens não vacinados em países com altas taxas de vacinação leva o foco para os jovens na pandemia.”
9 Jul, 2021 | 16:02hWill COVID become a disease of the young? – Nature
Perspectiva | “‘Bom demais para ser verdade’: dúvidas em torno do estudo que mostrou redução de 77% na mortalidade da COVID-19.”
9 Jul, 2021 | 16:00h‘Too good to be true’: Doubts swirl around trial that saw 77% reduction in COVID-19 mortality – Science (poucos artigos gratuitos por mês)
OMS | Países devem realizar reabertura cautelosa enquanto o mundo ultrapassa 4 milhões de mortes por COVID.
9 Jul, 2021 | 15:59hVer também: WHO: World at perilous point in pandemic – CIDRAP
Comentário relacionado no Twitter (fio – clique para saber mais)
I’m struggling with how best to stress how fragile the global situation is, so I’ll be blunt:
Each week >2.6 million cases and >53,000 deaths are reported to @WHO
Reported, meaning that there are many others.
Stop and think about that.
(Short thread⬇️) pic.twitter.com/OyQK98DkjR
— Maria Van Kerkhove (@mvankerkhove) July 6, 2021
M-A | Uso de medicamentos de supressão ácida durante hospitalização é um fator de risco para recorrência da infecção por Clostridioides difficile.
9 Jul, 2021 | 15:48hM-A | Comparação de eficácia e segurança de vancomicina, linezolida, tedizolida e daptomicina no tratamento de pacientes com infecção suspeita ou comprovada de pele e partes moles.
9 Jul, 2021 | 15:47h
Comentário no Twitter
🆕💥 Network Meta-Analysis @InfectDis_Ther
20 RCTs N=7804
Comparative Efficacy& Safety of Vancomycin,Linezolid,Tedizolid, and Daptomycin in Treating Patients with Suspected or Proven cSSTI
Linezolid was superior to vancomycin in improving clinical successhttps://t.co/qlZfXoWfaa pic.twitter.com/tO3sIoOMY4— Antibiotic Steward 🇵🇸💔Bassam Ghanem (@ABsteward) June 20, 2021
Coorte nacional prospectiva no Chile mostrou que a efetividade da CoronaVac foi de 65,9% para Covid-19 sintomática, 87,5% para hospitalizações, 90,3% para admissões em UTI e 86,3% para mortes.
8 Jul, 2021 | 09:57hEffectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile – New England Journal of Medicine
Relacionado: Phase 1/2 RCT: CoronaVac is well tolerated and safe and induces strong humoral responses in children and adolescents aged 3–17 years. E WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic. E Brazilian town experiment shows mass vaccination can wipe out COVID-19.
Comentário no Twitter
Chile's data on Sinovac CoronaVac in NEJM: not controlled study. Model details pic 2
– doses 28 days apart (like Serrana trial)
– symptomatic disease 65.9% (65-67)
– hospitalization 87.5% (87-88)
– intensive care 90.3% (89-91)
– Covid death 86.3% (85-88)
https://t.co/CB1U8Ar163 pic.twitter.com/4HwASRCnwQ— Hilda Bastian, PhD (@hildabast) July 7, 2021
Série de casos | Plasmaférese em 3 pacientes com trombocitopenia trombótica imune induzida por vacina.
8 Jul, 2021 | 09:56h
Comentário no Twitter
Three patients with severe manifestations of VITT after #COVID19 vaccination had poor response to initial therapy with anticoagulants and intravenous immune globulin. Their condition improved after therapeutic plasma exchange was initiated.
— NEJM (@NEJM) July 7, 2021
Novas evidências sugerem que a vacina Sputnik contra COVID é segura e eficaz.
8 Jul, 2021 | 09:55hMounting evidence suggests Sputnik COVID vaccine is safe and effective – Nature
COVID e escolas: evidências para a reabertura segura.
8 Jul, 2021 | 09:54hCOVID and schools: the evidence for reopening safely – Nature